2798 related articles for article (PubMed ID: 32800805)
1. COVID-19 Vaccine: A comprehensive status report.
Kaur SP; Gupta V
Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
[TBL] [Abstract][Full Text] [Related]
2. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
Samrat SK; Tharappel AM; Li Z; Li H
Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of SARS-CoV-2 vaccine candidates.
Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F
Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445
[TBL] [Abstract][Full Text] [Related]
4. Immunological considerations for COVID-19 vaccine strategies.
Jeyanathan M; Afkhami S; Smaill F; Miller MS; Lichty BD; Xing Z
Nat Rev Immunol; 2020 Oct; 20(10):615-632. PubMed ID: 32887954
[TBL] [Abstract][Full Text] [Related]
5. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
6. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
7. On the road to ending the COVID-19 pandemic: Are we there yet?
Case JB; Winkler ES; Errico JM; Diamond MS
Virology; 2021 May; 557():70-85. PubMed ID: 33676349
[TBL] [Abstract][Full Text] [Related]
8. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Gupta SP
Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
[TBL] [Abstract][Full Text] [Related]
9. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Smith BK; Shrihari S; McCune BT; Harvey IB; Keeler SP; Bloyet LM; Zhao H; Ma M; Adams LJ; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
Cell Host Microbe; 2020 Sep; 28(3):465-474.e4. PubMed ID: 32798445
[TBL] [Abstract][Full Text] [Related]
10. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Li H; Liu Z; Ge J
J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
[TBL] [Abstract][Full Text] [Related]
11. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
12. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
Dai L; Zheng T; Xu K; Han Y; Xu L; Huang E; An Y; Cheng Y; Li S; Liu M; Yang M; Li Y; Cheng H; Yuan Y; Zhang W; Ke C; Wong G; Qi J; Qin C; Yan J; Gao GF
Cell; 2020 Aug; 182(3):722-733.e11. PubMed ID: 32645327
[TBL] [Abstract][Full Text] [Related]
13. Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
Coudeville L; Gomez GB; Jollivet O; Harris RC; Thommes E; Druelles S; Chit A; Chaves SS; Mahé C
Vaccine; 2020 Nov; 38(48):7588-7595. PubMed ID: 33097312
[TBL] [Abstract][Full Text] [Related]
14. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
Al-Kassmy J; Pedersen J; Kobinger G
Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
[TBL] [Abstract][Full Text] [Related]
15. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P
Front Immunol; 2020; 11():2130. PubMed ID: 33013898
[TBL] [Abstract][Full Text] [Related]
16. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.
Galili U
Vaccine; 2020 Sep; 38(42):6487-6499. PubMed ID: 32907757
[TBL] [Abstract][Full Text] [Related]
17. Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.
Gupta T; Gupta SK
Int Immunopharmacol; 2020 Sep; 86():106717. PubMed ID: 32585611
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 immunogenicity at the crossroads.
Karamloo F; König R
Allergy; 2020 Jul; 75(7):1822-1824. PubMed ID: 32401346
[No Abstract] [Full Text] [Related]
19. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
Shih HI; Wu CJ; Tu YF; Chi CY
Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623
[TBL] [Abstract][Full Text] [Related]
20. The race for coronavirus vaccines: a graphical guide.
Callaway E
Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
[No Abstract] [Full Text] [Related]
[Next] [New Search]